Synovus Financial Corp Blueprint Medicines Corp Transaction History

Synovus Financial Corp

  • $9.33 Billion
  • Q3 2024

A detailed history of Synovus Financial Corp transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Synovus Financial Corp holds 24,047 shares of BPMC stock, worth $2.3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
24,047
Previous 23,125 3.99%
Holding current value
$2.3 Million
Previous $2.49 Million 10.79%
% of portfolio
0.02%
Previous 0.03%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$84.1 - $120.5 $77,540 - $111,101
922 Added 3.99%
24,047 $2.22 Million
Q2 2024

Aug 13, 2024
SELL
$85.18 - $108.78 $664,063 - $848,048
-7,796 Reduced 25.21%
23,125 $2.49 Million
Q1 2024

May 14, 2024
SELL
$73.17 - $99.79 $678,798 - $925,751
-9,277 Reduced 23.08%
30,921 $2.93 Million
Q3 2023

Nov 13, 2023
SELL
$46.9 - $66.0 $13,272 - $18,678
-283 Reduced 0.7%
40,198 $2.02 Million
Q2 2023

Aug 08, 2023
SELL
$42.2 - $66.37 $111,070 - $174,685
-2,632 Reduced 6.1%
40,481 $2.56 Million
Q1 2023

May 11, 2023
SELL
$37.97 - $50.0 $178,838 - $235,500
-4,710 Reduced 9.85%
43,113 $1.94 Million
Q4 2022

Feb 06, 2023
BUY
$41.06 - $66.48 $552,913 - $895,219
13,466 Added 39.19%
47,823 $2.1 Million
Q3 2022

Oct 27, 2022
BUY
$49.93 - $77.7 $240,063 - $373,581
4,808 Added 16.27%
34,357 $2.26 Million
Q2 2022

Aug 10, 2022
BUY
$45.23 - $70.15 $127,819 - $198,243
2,826 Added 10.58%
29,549 $1.49 Million
Q1 2022

May 12, 2022
BUY
$54.1 - $110.08 $287,703 - $585,405
5,318 Added 24.84%
26,723 $1.7 Million
Q4 2021

Feb 14, 2022
BUY
$94.25 - $115.99 $20,640 - $25,401
219 Added 1.03%
21,405 $2.29 Million
Q3 2021

Nov 08, 2021
BUY
$80.98 - $109.47 $491,872 - $664,920
6,074 Added 40.19%
21,186 $2.17 Million
Q2 2021

Aug 11, 2021
BUY
$82.78 - $101.0 $65,396 - $79,790
790 Added 5.52%
15,112 $1.33 Million
Q1 2021

May 11, 2021
BUY
$90.71 - $108.28 $1.3 Million - $1.55 Million
14,322 New
14,322 $1.39 Million
Q3 2020

Nov 09, 2020
SELL
$66.45 - $92.7 $4,186 - $5,840
-63 Closed
0 $0
Q3 2018

Nov 01, 2018
BUY
$58.91 - $78.32 $3,711 - $4,934
63 New
63 $5,000

Others Institutions Holding BPMC

# of Institutions
349
Shares Held
60.2M
Call Options Held
1.05M
Put Options Held
616K
View Full List

About Blueprint Medicines Corp

BPMC Quotes by TradingView
  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.71B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Synovus Financial Corp Portfolio

Follow Synovus Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Synovus Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email